<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVESHypertrophic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> is a complex and relatively common genetic <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> and has been the subject of intensive scrutiny and investigation for over 40 years </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this non-randomized cohort study was to compare subjective and objective outcomes in <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> patients undergoing drug therapy, surgical myotomy-myectomy, dual-chamber pacing and alcohol septal ablation.METHODSWe examined 194 patients: 103 with non-obstructive <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> and 91 with obstructive <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the patients with a non-obstructive form were on drug therapy </plain></SENT>
<SENT sid="3" pm="."><plain>Ninety-one consecutive patients with drug-refractory obstructive <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> were treated invasively </plain></SENT>
<SENT sid="4" pm="."><plain>Dual-chamber pacemaker implantation was performed for 49 patients with previous positive temporary pacing test (Group 1) </plain></SENT>
<SENT sid="5" pm="."><plain>In 28 patients with massive <z:mp ids='MP_0002625'>left ventricle hypertrophy</z:mp> and obliteration of its cavities, extensive myotomy-myectomy was performed (Group 2) </plain></SENT>
<SENT sid="6" pm="."><plain>In 14 patients with midventricular obstruction and appropriate coronary <z:mp ids='MP_0000002'>anatomy</z:mp>, alcohol septal ablation was performed (Group 3).RESULTSThe peak left ventricle outflow tract gradient was 84.1 ± 15.2 mmHg in Group 1, 113.3 ± 14.9 mmHg in Group 2 and 97.5 ± 8.9 mmHg in Group 3 </plain></SENT>
<SENT sid="7" pm="."><plain>Dual-chamber pacing in Group 1 with optimal atrio-ventricular delay (85-180 ms for atrium pacing and 45-120 ms for atrial sensing) leads to dramatic decreases in left ventricle outflow tract gradient to 17.6 ± 11.8 mmHg and degree of <z:hpo ids='HP_0001653'>mitral regurgitation</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>After extensive myectomy in Group 2, we observed a reduction of left ventricle outflow tract gradient to 17.3 ± 10.2 mmHg </plain></SENT>
<SENT sid="9" pm="."><plain>Septal alcohol ablation in Group 3 leads to a left ventricle outflow tract gradient decrease from 97.5 ± 8.9 to 25.3 ± 5.8 mmHg.CONCLUSIONSSurgical myectomy, dual-chamber pacing and alcohol septal ablation are equally effective in reducing obstruction in case of correct indications </plain></SENT>
<SENT sid="10" pm="."><plain>Dual-chamber pacing is indicated in functional reversible states characterized by excitation delay </plain></SENT>
<SENT sid="11" pm="."><plain>Alcohol septal ablation is preferable in cases with midventricular obstruction and appropriate coronary <z:mp ids='MP_0000002'>anatomy</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>Surgical methods are indicated in anatomical irreversible changes and remain the gold standard for obstructive <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> treatment </plain></SENT>
</text></document>